The NME8 Gene Primary Ciliary Dyskinesia Type 6 Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to detect mutations in the NME8 gene, which are known to cause Primary Ciliary Dyskinesia (PCD) Type 6. This condition is a rare genetic disorder characterized by chronic respiratory tract infections, abnormal organ positioning, and infertility, resulting from defective cilia and flagella motility. The test, priced at 4400 AED, involves analyzing the patient's DNA to identify mutations in the NME8 gene, providing crucial information for accurate diagnosis, management, and understanding the inheritance pattern of PCD Type 6. This test is particularly valuable for individuals with a family history of PCD or those exhibiting symptoms, offering them a clearer path towards appropriate treatment and genetic counseling.
The DNAH11 Gene Primary Ciliary Dyskinesia Type 7 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the DNAH11 gene that are associated with Primary Ciliary Dyskinesia (PCD) Type 7. This condition is a rare genetic disorder characterized by chronic respiratory tract infections, abnormal organ positioning, and fertility issues, arising from defects in the structure and function of cilia, which are tiny, hair-like structures that line the airways, reproductive system, and other parts of the body.
The test, priced at 4400 AED, involves collecting a DNA sample from the patient, usually through a blood draw or cheek swab. The sample is then analyzed in the laboratory using advanced genetic sequencing techniques to detect any mutations in the DNAH11 gene that are known to cause PCD Type 7. This precise genetic testing allows for an accurate diagnosis of the condition, enabling targeted treatment and management strategies to improve the quality of life for affected individuals.
DNA Labs UAE is recognized for its state-of-the-art facilities and expert team of geneticists and laboratory technicians, ensuring high-quality testing and reliable results for patients and their families. The availability of such a test represents a significant step forward in the diagnosis and understanding of Primary Ciliary Dyskinesia, offering hope for better management of this challenging condition.
The DNAI2 gene primary ciliary dyskinesia type 9 genetic test is a specialized diagnostic tool used to detect mutations in the DNAI2 gene, which are associated with primary ciliary dyskinesia (PCD) type 9. PCD is a rare genetic disorder characterized by chronic respiratory tract infections, abnormal organ positioning, and infertility, resulting from defects in the structure and function of cilia, which are tiny hair-like structures that line the airways, reproductive system, and other parts of the body.
This specific test aims to identify genetic alterations in the DNAI2 gene, which plays a crucial role in the development and function of cilia. Identifying mutations in this gene can help in confirming a diagnosis of PCD type 9, enabling targeted management and treatment strategies for affected individuals.
The test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The cost of the DNAI2 gene primary ciliary dyskinesia type 9 genetic test is 4400 AED. The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of mutations in the DNAI2 gene.
By offering this test, DNA Labs UAE provides a crucial resource for individuals and families affected by PCD type 9, facilitating early diagnosis and intervention, which can significantly improve the quality of life for those with the condition.
The COL4A6 Gene Deafness X-Linked Type 6 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to detect mutations in the COL4A6 gene, which are linked to a rare form of genetic deafness known as X-linked type 6. This condition is characterized by its mode of inheritance, which is X-linked, meaning the defective gene responsible for the disorder is located on the X chromosome. Individuals with mutations in the COL4A6 gene may exhibit varying degrees of hearing loss, which can range from mild to profound, often noticed from birth or early childhood.
The test is crucial for families with a history of X-linked deafness, as it helps in understanding the genetic underpinnings of their condition, enabling informed decisions regarding management, treatment options, and genetic counseling. It involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of specific mutations in the COL4A6 gene.
The cost of the COL4A6 Gene Deafness X-Linked Type 6 Genetic Test at DNA Labs UAE is 4400 AED. The price reflects the sophisticated technology and expertise required to accurately identify mutations in the COL4A6 gene. Individuals considering this test are encouraged to discuss it with their healthcare provider or a genetic counselor to ensure it is appropriate for their situation and to understand the implications of the test results.
The SLC52A3 gene plays a critical role in the human body by encoding for a transporter protein essential for the uptake of riboflavin (vitamin B2), which is crucial for mitochondrial function and overall cellular energy metabolism. Mutations in the SLC52A3 gene can lead to Fazio-Londe disease, a rare and severe neurological disorder that primarily affects the motor neurons, leading to muscle weakness and respiratory failure, often in childhood or early adolescence.
To diagnose this condition, a genetic test focusing on the SLC52A3 gene can be conducted. This test involves analyzing the patient's DNA to identify mutations in the SLC52A3 gene that are known to cause Fazio-Londe disease. It is a vital tool for confirming the diagnosis, which can then guide treatment and management strategies for affected individuals.
At DNA Labs UAE, the SLC52A3 Gene Fazio-Londe Disease Genetic Test is available for individuals who may be at risk of this condition, either due to symptoms or a family history of the disease. The test is priced at 4400 AED and involves a simple process of collecting a DNA sample, usually through a blood draw or cheek swab. The sample is then analyzed in the laboratory to detect any mutations in the SLC52A3 gene. Results from this test can provide crucial information for patients and their families regarding the diagnosis, prognosis, and potential treatment options for Fazio-Londe disease.
The MAP1A gene is known to play a critical role in the development and function of the inner ear, which is crucial for hearing. Mutations in the MAP1A gene can lead to various forms of hearing loss, making it a significant focus for genetic testing in individuals experiencing auditory issues without a clear cause. The MAP1A-related genetic test is a specialized diagnostic tool designed to identify mutations within the MAP1A gene that might be responsible for hearing loss. This test is particularly valuable for individuals with a family history of hearing loss or those who have hearing loss with an unknown etiology.
Conducted at DNA Labs UAE, the test offers a comprehensive analysis of the MAP1A gene, utilizing advanced genetic sequencing technologies to ensure accurate and reliable results. The process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect any genetic variations that could be linked to hearing loss.
The cost of the MAP1A-related genetic test at DNA Labs UAE is 4400 AED. This price includes the cost of sample collection, genetic analysis, and the provision of a detailed report that explains the results. The report not only offers insights into the genetic status of the MAP1A gene but also provides valuable information for healthcare providers to develop a personalized management or treatment plan for the affected individual.
This test is a crucial step towards understanding the genetic basis of hearing loss in affected individuals and can significantly impact the management and treatment of the condition, offering a pathway towards improved quality of life.
The MYH7B gene is implicated in a specific type of hearing loss, making the MYH7B related genetic test a crucial tool for individuals experiencing auditory issues potentially linked to genetic factors. This test aims to identify mutations in the MYH7B gene, which can provide essential insights into the diagnosis, prognosis, and treatment options for affected individuals. Conducted at DNA Labs UAE, a leading facility in genetic testing, the MYH7B test is thorough and reliable, ensuring high-quality results for patients seeking answers about their hearing loss conditions.
The cost of the MYH7B related genetic test is set at 4400 AED, reflecting the comprehensive analysis and detailed reporting provided. This investment can be invaluable for families and individuals facing the challenges of genetic-based hearing loss, offering a pathway to understanding and managing their condition more effectively. DNA Labs UAE employs cutting-edge technology and expert professionals to conduct this test, ensuring accuracy and confidentiality in handling sensitive genetic information.
The PEX1 Gene Heimler Syndrome Type 1 Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE, designed to detect mutations in the PEX1 gene, which are associated with Heimler Syndrome Type 1. Heimler Syndrome is a rare genetic disorder characterized by sensorineural hearing loss, dental anomalies, and, in some cases, visual impairments due to retinal dystrophy. The condition follows an autosomal recessive inheritance pattern, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
This genetic test is crucial for the early diagnosis and management of Heimler Syndrome, allowing for timely intervention and support for affected individuals. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to identify any mutations in the PEX1 gene.
The cost of the PEX1 Gene Heimler Syndrome Type 1 Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to accurately detect the presence of the genetic mutations associated with the syndrome. Early diagnosis through this test can significantly impact the quality of life for individuals with Heimler Syndrome, providing a pathway to appropriate treatments and support services.
The GJB2 Gene Keratitis Ichthyosis Deafness (KID) Syndrome Autosomal Dominant Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the GJB2 gene, which are linked to the development of KID syndrome. This condition is a rare genetic disorder characterized by the triad of keratitis (inflammation of the cornea), ichthyosis (dry, scaly skin), and congenital deafness. Being an autosomal dominant condition, a mutation in just one copy of the gene in each cell is sufficient to cause the disorder.
The test, priced at 4400 AED, involves analyzing the patient's DNA to detect mutations in the GJB2 gene, providing crucial information for the diagnosis, management, and genetic counseling of affected individuals and their families. Conducted at the state-of-the-art facilities of DNA Labs UAE, this genetic test stands as a significant step towards personalized medicine, enabling targeted treatment strategies and improved quality of life for those affected by KID syndrome.
The GJB2 Gene Keratoderma Palmoplantar with Deafness Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE. This test is designed to identify mutations in the GJB2 gene, which are associated with the development of palmoplantar keratoderma (PPK) and sensorineural deafness. PPK is a genetic disorder characterized by the thickening of the skin on the palms of the hands and the soles of the feet, while mutations in the GJB2 gene are also a common cause of congenital hearing loss.
The significance of this test lies in its ability to provide essential genetic information that can assist in the diagnosis, management, and treatment planning for individuals showing symptoms of these conditions. Early detection through genetic testing can lead to better outcomes by facilitating timely interventions.
The test is conducted at DNA Labs UAE, a leading facility known for its advanced genetic testing services. The cost of the GJB2 Gene Keratoderma Palmoplantar with Deafness Genetic Test is 4400 AED. This comprehensive genetic test is recommended for individuals with clinical symptoms of PPK and deafness, or for those with a family history of these conditions, aiming to provide them with a clearer understanding of their genetic predisposition and potential health risks.
